REFRACTORINESS TO PROTON PUMP INHIBITOR THERAPY IN ASYMPTOMATIC PATIENTS WITH BARRETT ESOPHAGUS

被引:0
|
作者
Pesce, M. [1 ]
Sannino, M. M. [1 ]
Pagliaro, M. [1 ]
Cefaliello, A. [1 ]
Maione, F. [1 ]
机构
[1] Univ Federico II Naples, Naples, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OC.08.7
引用
收藏
页码:S173 / S174
页数:2
相关论文
共 50 条
  • [31] Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus
    Kastelein, Florine
    Spaander, Manon C. W.
    Steyerberg, Ewout W.
    Biermann, Katharina
    Valkhoff, Vera E.
    Kuipers, Ernst J.
    Bruno, Marco J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (04) : 382 - 388
  • [32] The evidence base of proton pump inhibitor chemopreventative agents in Barrett's esophagus - The good, the bad, and the flawed!
    Leedham, Simon
    Jankowski, Janusz
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (01): : 21 - 23
  • [33] Acid suppression therapy with proton pump inhibitors does not improve inflammation in Barrett's esophagus
    Bansal, Ajay
    Mathur, Sharad
    Talapaneni, Jyotsna
    Singh, Shailender
    Wani, Sachin B.
    Rastogi, Amit
    Puli, Shnivas R.
    Sharma, Prateek
    GASTROENTEROLOGY, 2007, 132 (04) : A276 - A276
  • [34] Proton pump inhibitor and nonsteroidal anti-inflammatory use and the development of neoplasia in Barrett's esophagus
    Kuczcynski, John
    El-Scrag, Hashem
    Davis, Stephanie
    Wachter, Adam
    Stein, Daniel J.
    Sampliner, Richard E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S122 - S122
  • [35] Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett's esophagus
    Francisco Baldaque-Silva
    Michael Vieth
    Mumen Debel
    Bengt H?kanson
    Anders Thorell
    Nuno Lunet
    Huan Song
    Miguel Mascarenhas-Saraiva
    Gisela Pereira
    Lars Lundell
    Hanns-Ulrich Marschall
    World Journal of Gastroenterology, 2017, 23 (17) : 3174 - 3183
  • [36] Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett's esophagus
    Baldaque-Silva, Francisco
    Vieth, Michael
    Debel, Mumen
    Hakanson, Bengt
    Thorell, Anders
    Lunet, Nuno
    Song, Huan
    Mascarenhas-Saraiva, Miguel
    Pereira, Gisela
    Lundell, Lars
    Marschall, Hanns-Ulrich
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (17) : 3174 - 3183
  • [37] High-resolution Manometry Determinants of Refractoriness of Reflux Symptoms to Proton Pump Inhibitor Therapy
    Ribolsi, Mentore
    Savarino, Edoardo
    Rogers, Benjamin
    Rengarajan, Arvind
    Della Coletta, Marco
    Ghisa, Matteo
    Cicala, Michele
    Gyawali, C. Prakash
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 26 (04) : 447 - 454
  • [38] Dual Ambulatory pH Monitoring in Patients with Gastroesophageal Reflux Rendered Asymptomatic with Proton Pump Inhibitor Therapy
    Lin, David
    Triadafilopoulos, George
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (05) : 1343 - 1349
  • [39] Dual Ambulatory pH Monitoring in Patients With Gastroesophageal Reflux Rendered Asymptomatic With Proton Pump Inhibitor Therapy
    Lin, David
    Triadafilopoulos, George
    GASTROENTEROLOGY, 2014, 146 (05) : S166 - S166
  • [40] Dual Ambulatory pH Monitoring in Patients with Gastroesophageal Reflux Rendered Asymptomatic with Proton Pump Inhibitor Therapy
    David Lin
    George Triadafilopoulos
    Digestive Diseases and Sciences, 2015, 60 : 1343 - 1349